17 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... long-acting β2-agonist; ICS ... #Management #Pulmonary ... GOLD2017 #LAMA #LABA #ICS
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... of expiration; ICS ... LAMA #SABA #SAMA #ICS ... #Pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
5 or elevated Cr ... common • Imaging: CXR ... - pulmonary opacities ... initiation • Differential ... organ dysfuxtion, ICU
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
are common in ICU ... ulceration or treatment ... Risk Factors • Clinical ... #criticalcare #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... & Dry) is the treatment ... #diagnosis #differential ... #criticalcare #icu ... #clinical #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Therapy (LAMA/LABA/ICS ... recommendations for the treatment ... low, adding an ICS ... won’t have any clinical ... #Indications #Pharmacology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Clinical ... Blood cultures • CXR ... early disease) • CXR ... Lung #Abscess #pulmonary ... #differential #
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Clinical Picture ... life-threatening Differential ... Diagnosis - Clinical ... Clinical DX: - ... Bedside: ice pack
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... staining, NAA (PCR ... and Culture • CXR ... Tuberculosis Treatment ... disease • Check CXR
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... staining, NAA (PCR ... and Culture • CXR ... Tuberculosis Treatment ... disease • Check CXR